Results

1–10 of 27 results for Choroidal Neovascularization

Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD
Neil M. Bressler, MD
Annual Meeting Talks
2022
Subretinal Fibrosis in Patients With Choroidal Neovascularization Based on Spectral-Domain Optical Coherence Tomography Classification: Findings from the HARBOR Trial
On Demand Cases, Courses, and Papers
2022
Subretinal Hemorrhage
Akansha Sharma
Retina Image Bank: Images of the Week
2023
The Role of Subretinal Surgery in the Treatment of Resistant Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Nabil M. Jabbour, MD, FACS
On Demand Cases, Courses, and Papers
2021
Choroidal Disturbance in Polypoidal Choroidal Vasculopathy: Insights From Dynamic Indocyanine Green Angiography
Gemmy Chui Ming Cheung, FRCOphth
Updates from the Field
2022
A 10-Year Follow-up on Outcomes of Intravitreal Anti-VEGF Injections for Choroidal Neovascularization Secondary to Ocular Histoplasmosis
Carl Noble, DO, MBA
Annual Meeting Talks
2021
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Choroidal Neovascularization in AMD (ForeseeHomeDevice)
Allen C Ho, MD FASRS
Annual Meeting Talks
2020
Ziv-aflibercept Efficacy in Better Regulating Neovascular AMD (ZEBRA) Trial
Kapil G. Kapoor, MD
On Demand Cases, Courses, and Papers
2019
Treatment course and outcomes of neovascular age-related macular degeneration in patients receiving intraocular pressure-lowering drops
Bobeck S Modjtahedi, MD
On Demand Cases, Courses, and Papers
2019
Real World Patient and Clinical Characteristics in Treatment Naive Neovascular Age-Related Macular Degeneration
Matthew P. Ohr, MD
On Demand Cases, Courses, and Papers
2019